ClinVar Miner

Submissions for variant NM_138477.4(CDAN1):c.3124C>T (p.Arg1042Trp)

dbSNP: rs80338697
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
CeGaT Center for Human Genetics Tuebingen RCV001092491 SCV001249027 pathogenic not provided 2019-04-01 criteria provided, single submitter clinical testing
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV001544511 SCV002507064 likely pathogenic Anemia, congenital dyserythropoietic, type 1a 2022-05-04 criteria provided, single submitter curation The homozygous p.Arg1042Trp variant in CDAN1 was identified by our study in 1 individual with anemia, congenital dyserythropoietic, type 1a. The variant has been reported in at least 10 Israeli Bedouin individuals with anemia, congenital dyserythropoietic, type 1a (PMID: 12434312, 18081704), segregated with disease in at least 4 affected relatives from at least one family (PMID: 12434312), and has been identified in 0.01% (1/9396) of Ashkenazi Jewish and 0.006% (1/16548) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs80338697). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID: 3176) as pathogenic by OMIM, GeneReviews, and CeGaT Praxis fuer Humangenetik Tuebingen. In vitro functional studies provide some evidence that the p.Arg1042Trp variant may impact protein function (PMID: 22407294). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in at least 10 affected homozygotes, and in at least 10 individuals with anemia, congenital dyserythropoietic, type 1a increases the likelihood that the p.Arg1042Trp variant is pathogenic (PMID: 12434312, 18081704). Multiple variants in the same region as p.Arg1042Trp have been reported in association with disease, suggesting that this variant is in a hot spot and slightly supports pathogenicity (PMID: 18081704). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PP1_strong, PM3, PM1_supporting, PS3_supporting, PP3 (Richards 2015).
OMIM RCV000020956 SCV000023484 pathogenic Congenital dyserythropoietic anemia, type I 2002-12-01 no assertion criteria provided literature only
GeneReviews RCV001544511 SCV000041581 not provided Anemia, congenital dyserythropoietic, type 1a no assertion provided literature only Founder variant in Bedouin population

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.